FIELD: medicine, pharmaceutics.
SUBSTANCE: invention concerns pharmaceutical industry and medicine, namely to creation of an agent for treatment and prevention of benign hyperplasia of prostate (BPH), prostatitis, impotency, sterility and a cancer of prostate and a method of its application. The agent and method of application of an agent on the basis of camphor (dextrogyrate [D-] either levogyratory (L-) or racemic [DL-camphor] in the form of fat-oil-dimexide emulsion (Emulsio Camphorae Axungio Oleo - Dimexidosa), oil-water emulsion (Emulsio Camphorae Oleo-Aguosa) and in the form of candles where quantity of camphor totals 0.1-15.0 are offered. The presented agents are applied rectal. The oil-fat-dimexide emulsion can be applied for prevention of cancer of prostate, or a candle, 1 time a day by courses up to 20 days annually. Camphor preparations raise fastness of tissue colloids, show opposing action in relation to capillary poisons, activate erection centre of sacrum of parasympathetic nervous system, posses M - and N - cholinolytic action, tone up the centre of the ejaculation, located in sympathetic part of the central nervous system, normalise tonus of capillaries and venules, stimulate vasculomotor centres of a spinal cord, strengthen synthesis of high-energy phosphates and brake splitting of ATF-ACID in the conditions of hypoxia, possess analgesic, bactericidal and fibrinolitic action. Application of treatment methods and prevention of BPH, prostatitis, impotency, sterility and cancer of prostate with use of camphor preparations; dilates assortment of preparations and methods of treatment applied to ill with BPH, prostatitis, sterility, impotency; allows to spend preventive treatment of these diseases within many decades.
EFFECT: expansion of assortment of preparations and methods of treatment and prevention, applied to patients with BPH, prostatitis, sterility, an impotency.
15 cl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TREATMENT AND PROPHYLAXIS OF BENIGN PROSTATE HYPERPLASIA, PROSTATITIS, IMPOTENCE, INFERTILITY AND PROSTATE CANCER | 1998 |
|
RU2140265C1 |
MEDICATION FOR TREATMENT AND PREVENTION OF BENIGN PROSTATIC HYPERPLASIA AND ERECTILE DYSFUNCTION IN MEN | 2009 |
|
RU2397772C1 |
AGENT FOR PREVENTING AND TREATING PROSTATITIS AND PROSTATE ADENOMA | 2013 |
|
RU2538615C1 |
BIOLOGICALLY ACTIVE COMPOSITION | 2012 |
|
RU2529812C2 |
METHOD AND REMEDY FOR TREATMENT AND PREVENTION OF BENIGN PROSTATIC HYPERPLASIA | 2019 |
|
RU2764850C1 |
METHOD OF CHRONIC PROSTATITIS AND PROSTATE ADENOMA OF THE 1-ST STAGE TREATMENT | 0 |
|
SU1801009A3 |
AGENT FOR REDUCING PATHOLOGICAL CHANGES IN PROSTATIC HYPERPLASIA | 2020 |
|
RU2740946C1 |
METHOD OF TREATING BENIGN PROSTATIC HYPERPLASIA | 2009 |
|
RU2408399C1 |
PHYTOCONCENTRATE OF CURATIVE-PROPHYLACTIC EFFECT FOR PATIENTS WITH PROSTATE DISEASE | 1997 |
|
RU2122422C1 |
METHOD FOR PREVENTING AND TREATING BENIGN PROSTATIC HYPERPLASIA | 2014 |
|
RU2574014C2 |
Authors
Dates
2008-10-27—Published
2007-05-03—Filed